September 29, 2026
CDC Reports Likely Sustained Clade Ib Mpox Transmission in U.S., GeoVax Calls for Vaccine Preparedness
September 28, 2026
South Korean Researchers Identify Protein That Controls Brain Cancer Growth, Offering New Hope for Glioblastoma Patients
September 28, 2026
TransCode Therapeutics Reports Updated Phase 1a Data for TTX-MC138 in Advanced Solid Tumors
September 25, 2026
Psychiatrist Dr. Amar Surdhar Backs HAS Foundation to Advance Neurological Health and Compassionate Care
September 24, 2026
VERAXA Biotech Shifts Focus to Oncology Pipeline After Nasdaq Debut, Xlife Sciences Reports First-Half Progress
September 23, 2026
Quantum BioPharma Pursues New Path for Better Multiple Sclerosis Treatments with Lucid-MS
September 23, 2026
Waist-to-Height Ratio Emerges as Reliable, Low-Cost Screening Tool for Pediatric MASLD Across Diverse Populations
September 22, 2026
VERAXA Biotech Advances Oncology Pipeline Around BiTAC Platform After NASDAQ Listing
September 22, 2026
Quantum BioPharma Takes Aim at Multiple Sclerosis with Novel Drug Candidate Lucid-MS
September 22, 2026
TransCode Therapeutics Expands Global Patent Portfolio for RNA-Based Cancer Therapies
September 22, 2026
Lantern Pharma Secures USPTO Notice of Allowance for LP-284 Patent, Extending IP Protection to 2042
September 22, 2026
American Heart Association and American Headache Society Co-Fund First-of-Its-Kind Migraine-Stroke Research
September 21, 2026
VERAXA Biotech Enters Next Phase as NASDAQ-Listed Oncology Company Focused on BiTAC Platform
September 21, 2026
GeoVax Preclinical Data Show Single-Dose MVA Vaccine Protects Against Lethal Clade I Mpox
September 18, 2026
Onco-Innovations Advances Lead Cancer Candidate ONC010 Toward First-in-Human Testing
September 17, 2026
VERAXA Biotech Appoints Capital Markets Veteran Raju Willener as CFO to Drive Oncology Pipeline
September 10, 2026
VERAXA Biotech Appoints Dr. Christoph Erkel as CSO to Steer BiTAC® Toward Clinical Trials
September 10, 2026
Quantum BioPharma Advances Multiple Sclerosis Drug Lucid-MS Toward Phase 2 Trial After FDA Clearance
September 10, 2026
Onco-Innovations CMO Highlights Dual Mechanism of PNKP Inhibitor ONC010 in BioMedWire Podcast
September 10, 2026
Quantum BioPharma’s Lucid-MS Advances Toward Phase 2 Multiple Sclerosis Trial After FDA Clearance
September 10, 2026
Dr. Wael Sakr Launches $1,000 Scholarship for Aspiring Medical Students Nationwide
September 9, 2026
Kairos Pharma CEO to Present at H.C. Wainwright Conference, Highlighting New Approach to Cancer Drug Resistance
September 9, 2026
GeoVax Welcomes Global Mpox Vaccine Stockpile, Highlights GEO-MVA’s Role in Diversifying Supply
September 9, 2026
Creative Biolabs Expands Single-Cell Multi-Omics and RNA Sequencing Services to Advance Biomedical Research
September 9, 2026
Tumor Microenvironment Drives Natural Killer Cell Diversity, Reshaping Cancer Immunotherapy Landscape
September 8, 2026
VERAXA Biotech Appoints Raju Willener as CFO to Drive Capital Strategy and Pipeline Growth
September 8, 2026
Onco-Innovations Advances ONC010 Toward Clinical Trials with Manufacturing and Capital Milestones
September 8, 2026
Quantum BioPharma Gets FDA Clearance for Phase 2 Trial of First-in-Class MS Drug Candidate
September 8, 2026
Quantum BioPharma Gets FDA Green Light for First-in-Class MS Drug Targeting Myelin Repair
September 8, 2026
Quantum BioPharma Cleared to Begin Phase 2 Trial of Lucid-MS for Multiple Sclerosis
September 7, 2026
Youth Tobacco Use Hits Historic Lows, but Adult Smokers Need Better Options, Says PMI U.S. Executive
September 4, 2026
Onco-Innovations Advances ONC010 Toward Clinical Trials with Key Manufacturing Milestones
September 4, 2026
VERAXA Biotech Appoints Veteran Finance Executive Raju Willener as CFO to Drive Capital Strategy and Oncology Pipeline Growth
September 3, 2026
OS Therapies to Present at Moody Capital Conference Amid Key Regulatory Milestones for OST-HER2
September 3, 2026
Immunotherapy Before Surgery May Improve Glioblastoma Outcomes, Preclinical Study Finds
September 2, 2026
Protecting the Thymus During Lung Cancer Treatment Could Improve Outcomes, Study Finds
September 1, 2026
Harrisburg Hematologist Dr. Salman Fazal Earns Third Consecutive Castle Connolly Top Doctor Honor
August 31, 2026
NanoViricides Advances NV-387 Measles Treatment Toward Phase II Trial Amid Rising Cases
August 31, 2026
TransCode Therapeutics Reports Survival Benefit in Preclinical Breast Cancer Bone Metastasis Study
August 30, 2026
Nurse’s Metastatic Breast Cancer Journey Highlights Importance of New Treatment Options
August 26, 2026
Heidelberg Pharma and Huadong Medicine Secure NMPA Approval for HDP-101 Combination Trial in China
